Yeni Başlayan Böbrek Yetmezliğinin Endovasküler Aort Onarımı Yapılan Hastalarda Mortalite Oranlarına Etkisi

Year 2023, Volume: 33 Issue: 2, 169 - 173, 30.04.2023

Elif Coşkun Sungur , Levent Altınay , Anıl Tekin , Sıtkı Turan , Ufuk Tütün

https://doi.org/10.54005/geneltip.1224194

Abstract

Amaç: Aort patolojilerinde özellikle inen torasik ve abdominal aortayı içeren aort diseksiyonlarında visseral organ kan dolaşımı ciddi şekilde bozulur. Bu çalışmada EVAR ve TEVAR uygulanan hastalarda yeni başlayan böbrek fonksiyon bozukluğunun postoperatif mortalite oranlarına etkisini belirlemeyi amaçladık.

Yöntemler: Bu retrospektif çalışmaya kliniğimizde EVAR/TEVAR işlemi uygulanan hastalar dahil edildi. Hastalar böbrek fonksiyon bozukluğu varlığına göre iki gruba ayrıldı. Gruplar için ölüm oranları hesaplandı.

Bulgular: Kasım 2016 ile Mayıs 2021 arasında EVAR/TEVAR prosedürü uygulanan toplam 60 hasta bu çalışmaya dahil edildi. Grup 1, postoperatif böbrek fonksiyon bozukluğu olmayan 48 (%80) hastayı içermiştir. Grup 2'de postoperatif böbrek fonksiyon bozukluğu olan toplam 12 (%20) hasta vardı. Verilerin ilk analizi, grupların yaş ve cinsiyet değişkenlerinde anlamlı farklılıklar olduğunu ortaya koydu (sırasıyla P=0.038 ve P=0.008). Daha sonra gruplarda yanlılığı önlemek için eğilim skoru eşleştirmesi yapıldı. Eğilim skoru eşleştirmesinden sonra Grup 1'e postoperatif böbrek yetmezliği olmayan 12 (%50) hasta ve Grup 2'ye postoperatif renal disfonksiyonu olan 12 (%50) hasta dahil edildi. Eğilim eşleştirmesinden sonra gruplar arasında önemli farklılıklar yoktu. Ölüm oranı gruplar arasında önemli ölçüde farklıydı.

Sonuçlar: EVAR/TEVAR prosedürlerinden sonra böbrek fonksiyonları dikkatle izlenmelidir çünkü böbrek yetmezliği postoperatif mortalite ile yakından ilişkilidir. Düzenli olarak uygulanan EVAR/TEVAR işlemleri sonrası böbrek fonksiyonları ve mortalite ilişkisi konusunda daha geniş hasta sayıları ile daha fazla araştırma yapılması gerektiğini düşünüyoruz.

Keywords

endovasküler onarım, böbrek yetmezliği, mortalite

The Effect of Newly Onset Renal Impairment on the Mortality Rates of the Patients Undergoing Endovascular Aortic Repair

Abstract

Abstract

Background: Visceral organ blood circulation is seriously impaired in aortic pathologies especially aortic dissection involving descending thoracic and abdominal aorta. Herein, we aimed to determine the effect of the newly onset renal function impairment on postoperative mortality rates of the patients undergoing EVAR and TEVAR procedures.

Methods: Patients who underwent an EVAR / TEVAR procedure in our clinic included in this retrospective study. Patients were divided into two groups according to the presence of renal function impairment. Mortality rates were calculated for the groups.

Results: A total of 60 patients who underwent an EVAR/TEVAR procedure between November 2016 and May 2021 included in this study. Group 1 included a number of 48 (80%) patients without postoperative renal dysfunction. Group 2 included a total of 12 (20%) patients with postoperative renal function impairment. The initial analysis of the data revealed significant differences in the age and sex variables of the groups (P=0.038 and P=0.008 respectively). Then propensity score matching was performed to avoid bias in the groups. After propensity score matching Group 1 included 12 (50%) patients without postoperative renal impairment and Group 2 included 12 (50%) patients with postoperative renal dysfunction. There were no significant differences between the groups after propensity matching. Mortality rate was significantly different between the groups which was 1 patient (8.33%) in Group 1 vs 6 (50.00%) patients in Group 2 (P=0.020).

Conclusions: Renal functions after EVAR/TEVAR procedures should be carefully monitored because renal impairment is closely related with postoperative mortality. We suggest that more studies with larger patient numbers should be conducted on the relation of renal functions and mortality after regularly performed EVAR/TEVAR procedures.

Keywords

endovascular aortic repair, renal impairment, mortality

References

• Greenhalgh RM. Commentary: impact of EVAR and DREAM trials on clinical practice. Endovasc Ther. 2007;14:541–3.
• Saratzis AN, Goodyear S, Sur H, Saedon M, Imray C, Mahmood A. Acute kidney injury after endovascular repair of abdominal aortic aneurysm. J Endovasc Ther. 2013;20:315–30.
• Saratzis A, Melas N, Mahmood A, Sarafidis P. Incidence of Acute Kidney Injury (AKI) after Endovascular Abdominal Aortic Aneurysm Repair (EVAR) and Impact on Outcome. Eur J Vasc Endovasc Surg. 2015;49:534–40.
• Chen X, Bai M, Sun S, Chen X. Outcomes and risk management in type B aortic dissection patients with acute kidney injury: a concise review. Ren Fail. 2021;43:585–96.
• Wang GJ, Fairman RM, Jackson BM, Szeto WY, Pochettino A, Woo EY. The outcome of thoracic endovascular aortic repair (TEVAR) in patients with renal insufficiency. J Vasc Surg. 2009;49:42–6.
• Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
• Altınay L, Coşkun Sungur E, İnce İ. The relation between neurological outcomes and in-hospital mortality rates of endovascular aortic repair patients. Genel Tıp Derg. 2022;32:113–9.
• Nienaber CA, Clough RE. Management of acute aortic dissection. Lancet (London, England). 2015;385:800–11.
• Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, et al. Aortic dissection. Nat Rev Dis Prim. 2016;2:16053.
• Hughes GC. Management of acute type B aortic dissection; ADSORB trial. J Thorac Cardiovasc Surg. 2015;149:S158-62.
• Ruan Z-B, Zhu L, Yin Y-G, Chen G-C. Risk factors of early and late mortality after thoracic endovascular aortic repair for complicated stanford B acute aortic dissection. J Card Surg. 2014;29:501–6.
• Najjar M, Salna M, George I. Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes. Expert Rev Cardiovasc Ther. 2015;13:301–16.
• Hoogmoed RC, Patel HJ, Kim KM, Williams DM, Deeb GM, Yang B. Acute Kidney Injury in Acute Type B Aortic Dissection: Outcomes Over 20 Years. Ann Thorac Surg. 2019;107:486–92.
• Luo S, Ding H, Luo J, Li W, Ning B, Liu Y, et al. Risk factors and early outcomes of acute renal injury after thoracic aortic endograft repair for type B aortic dissection. Ther Clin Risk Manag. 2017;13:1023–9.
• Zhu J-C, Chen S-L, Jin G-Z, Shao M-X, Kan J, Lu C-Y, et al. Acute renal injury after thoracic endovascular aortic repair of Stanford type B aortic dissection: Incidence, risk factors, and prognosis. J Formos Med Assoc. 2014;113:612–9.
• Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Dahlberg SE, Schermerhorn ML. Population-based outcomes following endovascular and open repair of ruptured abdominal aortic aneurysms. J Endovasc Ther. 2009;16:554–64.
• Prinssen M, Verhoeven ELG, Buth J, Cuypers PWM, van Sambeek MRHM, Balm R, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351:1607–18.
• Adriaensen MEAPM, Bosch JL, Halpern EF, Myriam Hunink MG, Gazelle GS. Elective Endovascular versus Open Surgical Repair of Abdominal Aortic Aneurysms: Systematic Review of Short-term Results. Radiology. 2002;224:739–47.
• Hua HT, Cambria RP, Chuang SK, Stoner MC, Kwolek CJ, Rowell KS, et al. Early outcomes of endovascular versus open abdominal aortic aneurysm repair in the National Surgical Quality Improvement Program–Private Sector (NSQIP–PS). J Vasc Surg. 2005;41:382–9.
• Gawenda M, Brunkwall J. Renal Response to Open and Endovascular Repair of Abdominal Aortic Aneurysm: A Prospective Study. Ann Vasc Surg. 2008;22:1–4.
• Blankensteijn JD, de Jong SECA, Prinssen M, van der Ham AC, Buth J, van Sterkenburg SMM, et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005;352:2398–405.
• Siracuse JJ, Gill HL, Graham AR, Schneider DB, Connolly PH, Sedrakyan A, et al. Comparative safety of endovascular and open surgical repair of abdominal aortic aneurysms in low-risk male patients. J Vasc Surg. 2014;60:1154–8.
• Zapata Chica CA, Serna Higuita LM, Nieto Ríos JF, Casas Arroyave FD, Donado Gómez JH. Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy : a systematic review and meta-analysis. Colomb Med. 2015;90–103.
• Zhang B, Liang L, Chen W, Liang C, Zhang S. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis. BMJ Open. 2015;5:e006989–e006989.
• Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, et al. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy. Ann Intern Med. 2016;164:406.
• Xu R, Tao A, Bai Y, Deng Y, Chen G. Effectiveness of N ‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2016;5.
• Kang X, Hu D-Y, Li C-B, Ai Z-S, Peng A. N -acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren Fail. 2015;37:297–303.
• Loomba RS, Shah PH, Aggarwal S, Arora RR. Role of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy. Am J Ther. 2016;23:e172–83.
• Zhao S, Zhong Z, Qi G, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials. Int J Cardiol. 2016;221:251–9.
• Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract. 2012;120:c179–84.
• Aguiar Lucas L, Rodriguez-Lopez JA, Olsen DM, Diethrich EB. Endovascular repair in the thoracic and abdominal aorta: no increased risk of spinal cord ischemia when both territories are treated. J Endovasc Ther. 2009;16:189–96.
• Xanthopoulos DK, Papakostas JC, Arnaoutoglou HM, Kouvelos GN, Michalis LK, Matsagas MI. Simultaneous endovascular stent-graft repair of descending thoracic and abdominal aortic pathologies. Report of four cases. Int Angiol. 2010;29:273–7.
• Crawford ES, Cohen ES. Aortic aneurysm: a multifocal disease. Presidential address. Arch Surg. 1982;117:1393–400.
• Scali ST, Feezor RJ, Chang CK, Stone DH, Goodney PP, Nelson PR, et al. Safety of elective management of synchronous aortic disease with simultaneous thoracic and aortic stent graft placement. J Vasc Surg. 2012;56:957-64.e1.
• Piffaretti G, Bonardelli S, Bellosta R, Mariscalco G, Lomazzi C, Tolenaar JL, et al. Spinal cord ischemia after simultaneous and sequential treatment of multilevel aortic disease. J Thorac Cardiovasc Surg. 2014;148:1435-1442.e1.
• Mehta M, Byrne J, Darling RC, Paty PSK, Roddy SP, Kreienberg PB, et al. Endovascular repair of ruptured infrarenal abdominal aortic aneurysm is associated with lower 30-day mortality and better 5-year survival rates than open surgical repair. J Vasc Surg. 2013;57:368–75.
• Mathlouthi A, Nejim B, Magee GA, Siracuse JJ, Malas MB. Hospitalization Cost and In-hospital Outcomes Following Type B Thoracic Aortic Dissection Repair. Ann Vasc Surg. 2021;75:22–8.